Two factors may help mitigate further volatility. BY JURRIEN TIMMER, DIRECTOR OF GLOBAL MACRO FOR FIDELITY MANAGEMENT & RESEARCH COMPANY (FMRCO), FIDELITY Key takeaways The S&P 500 Index entered the week of April 6 down 27% from the high and up 14% from the low set on March 23.At this point it is anyone’s guess whether significant new price lows are…
US Stock Market May Be In A Holding Pattern
A financial market resource for the every-day investor and trader.
-
Weekly State of the Market: Bond Market Volatility Persists
Seth Golden, , Research Reports, 0
Welcome to this week’s State of the Markets. Please click the following link to review this week’s SOTM. In this week’s...
-
VIX Trading: Even The Pros Get It Wrong
Seth Golden, , Research Reports, 0
It can sometimes be a little confusing to the average investor when the media and financial market communities throw...
-
Energy positive returns 6 consecutive months. Stick with Epicenter in 2H2021.
Seth Golden, , Research Reports, 0
STRATEGY: Stick with Epicenter in 2H2021. Strong markets stay strong. US COVID-19 deaths are “unvaccinated” Americans COVID-19 cases could...
-
The J.P. Morgan View – Global Asset Allocation
Seth Golden, , Research Reports, 0
Cross-Asset Strategy: With equities trading near last summer’s highs and at above-average multiples, despite weakening earnings and the recent...
-
-
Merrill Lynch & Charles Schwab: Macro Risks Afoot
Seth Golden, , Research Reports, 0
Merrill Lynch: Macro Risk Macro Strategy—Risky Business (Cycle): We believe the probability of a recession this year is low...
-
Alpha Insights Q417 Updated Earnings Estimates
Seth Golden, , Research Reports, 0
Aggregate Estimates and Revisions by David Aurelio Fourth quarter earnings are expected to increase 11.9% from Q3 2016. Excluding the...
-
Morgan Stanley: Reaching Herd Immunity
Seth Golden, , Research Reports, 0
When can the US achieve broad vaccination of its population: Using the current rate of daily vaccinations (red line,...
Recent Articles
Featured Products
- JPM Market Recap $0.00
- JPM Research Note $0.00
- JP Morgan Market Volatility Report $0.00